HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Gilead Sciences, Inc. (GILD)
60.79  0.12  (0.2%) 10-25 12:04
Open: 63.38 High: 63.64
Pre.close: 60.67 Low: 60.76
Volume: 30,965,444 Ave vol: 9,647,715
52w High: 85.97 52w Low: 59.65
MA(50): 63.296 MA(200): 71.573
EPS: -0.204 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers General
Website: https://www.gilead.com/
Market Cap (M): 76,214
Shares Out (M): 1,254
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 11,000 full-time employees. The firm's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. The company offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The company had operations in more than 30 countries, as of December 31, 2016.
Technical analysis
Overall: Outperform
MA: Bearish MACD: Bearish
KDJ: Bullish RSI: Bullish
Target 1: 73.53 Target 2: 75.91
Resist 1: 62.95 Resist 2: 64.99
Support 1: 59.65 Support 2: 49.63
Company key metrics
Revenue per Share: 17.6764
Net Income per Share: 4.2409
Cash per Share: 9.1583
Book Value per Share: 17.7362
Price to Sales: 3.5573
Price to Book Value: 3.5453
Earnings Yield: 0.0674
Dividend Yield: 0.0403
Debt to Equity: 1.7359
Debt to Assets: 0.6345
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.